Primary hyperparathyroidism and metastatic carcinoma within parathyroid gland

Journal of Clinical Pathology

Volumn 60, Issue 9, 2007, Pages 1058-1060

  Venkatraman, L ^a,b   Kalangutkar, A ^a   Russell, C F ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

AGED; ARTICLE; BONE DENSITY; CASE REPORT; CHEMICAL ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; OSTEOPOROSIS; PARATHYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RADIODIAGNOSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; FATAL OUTCOME; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INCIDENTAL FINDINGS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; PARATHYROID NEOPLASMS;

EID: 34548829660     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.035352     Document Type: Article

References (15)

1. Gattuso P, Khan NA, Jablokow VR, et al. Neoplasms metastatic to parathyroid glands. South Med J 1988;81:1467.
2. Horwitz CA, Myers WP, Foote FW Jr. Secondary malignant tumors of the parathyroid gland. Report of 2 cases with associated hypoparathyroidism. Am J Med 1972;52:797-808.
3. De la Monte SM, Hutchins GM, Moore GW. Endocrine organ metastases from breast carcinoma. Am J Pathol 1984;114:131-6.
4. Sidhu S, Neill AK, Russell CFJ. Long-term outcome of unilateral parathyroid exploration for primary hyperparathyroidism due to presumed solitary adenoma. World J Surg 2003;27:339-42.
5. DeLellis RA. Miscellaneous lesions. In: DeLellis RA, eds. Atlas of tumor pathology. Tumors of the parathyroid gland. Washington, DC: Armed Forces Institute of Pathology, 1993:93-4.
6. Tang W, Kakudo K, Nakamura Y, et al. Parathyroid gland involvement by papillary carcinoma of the thyroid gland. Arch Pathol Lab Med 2002;26:1511-14.
7. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373-9.
8. Solimando DA. Overview of hypercalcemia of malignancy. Am J Health Syst Pharm 2001;58(Suppl 3):4-7.
9. Matsumoto J, Kojima T, Shimizu T, et al. A case of lung cancer with hypercalcemia which was incidentally complicated with primary hyperparathyroidism due to parathyroid adenoma. Ann Thorac Cardiovasc Surg 2002;3:151-3.
10. Attie JN, Vardhan R. Association of hyperparathyroidism with nonmedullary thyroid carcinoma: review of 31 cases. Head Neck 1993;1:20-3.
11. Kara IO, Sahin B, Yapar Z. Breast cancer and concomitant primary hyperparathyroidism: description of two patients. Acta Med Austriaca 2004;3:81-4.
12. Axelrod DM, Bockman RS, Wong GY, et al. Distinguishing features of primary hyperparathyroidism in patients with breast cancer. Cancer 1987;60:1620-4.
13. Haar JG, Boulos FJ. Primary hyperparathyroidism and laryngeal carcinoma: a cause of associated hypercalcemia. Laryngoscope 1981;11:1937-40.
14. Godsall JW, Burtis WJ, Insogna KL, et al. Nephrogenous cyclic AMP, adenylate cyclase stimulating activity and the humoral hypercalcemia of malignancy. Recent Prog Horm Res 1986;42:705-50.
15. Honda M, Tsukada T, Horiuchi T, et al. Primary hyperparathyroidism associated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene. Intern Med 2004;43:310-14.